Pembrolizumab,Vibostolimab,Gebasaxturev,MK-4830,Favezelimab
Merck
['vibostolimab', 'melanoma', 'pembro']
keymaker u02 trial: in neoadjuvant melanoma therapy adding intralesional cocksakie virus to pembrolizumab failed to increase pcr and anti-tigit vibostolimab showed a a slight improvement at #aacr23 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment